Protein Signal Launches Another New Best Antibody: Mouse Anti-PEG Antibody

Piscataway, New Jersey (PressExposure) February 21, 2013 -- Protein Signal now offers a Mouse Anti-PEG Monoclonal Antibody (Catalog No.: A01795-100, A01795-500). This antibody is a new member of THETM Elite series, which represents THE best quality antibody in the industry.

PEG (Polyethylene glycol) is a polyether compound with many applications, from industrial manufacturing to medicine. PEGylation, which is an FDA-approved method of protein drug delivery, is the process of covalently coupling non-toxic, hydrophilic PEG molecules to a larger molecule. PEG modification can reduce the drug immunogenicity and antigenicity, decelerate renal excretion, improve stability towards proteolysis, and increase its half-life in blood. Accurate and sensitive quantification of PEG conjugates is important for PEG conjugated product development and pharmaceutical study. The polyethylene glycol (PEG) antibody is a useful tool for the detection of PEGylated molecules.

Currently, Protein Signal is having a "Find a better PEG antibody" special, guaranteeing to refund the money if customers find any PEG antibody product better than Protein Signal's. Protein Signal will develop other related products this year, such as Anti-PEG Antibody ELISA kits and labeling antibodies.

Specifications:

Applications: Qualified for ELISA Capturer & Detector, Competitive ELISA, Double Antigen Bridging ELISA, Western Blot, Immunohistochemistry.

Specificity: High affinity for the PEG backbone. The antibody binds to a variety of PEGs such as PEG40K, PEG20K, PEG5K, PEG12, PEGylated drugs, and PEG conjugates.

Immunogen: PEG conjugated to KLH

Purification Method: Affinity chromatography

Fusion Partner: Spleen cells were fused with SP2/0-Ag14 mouse myeloma cells.

For more information, please click PEG Antibody. Source: [http://www.proteinsignal.com]

About GENSCRIPT USA Inc.

GenScript, the largest gene synthesis supplier in the USA, is an internationally recognized Contract Research Organization (CRO) specializing in biological research and early-phase drug discovery services. In 2011, more than 2300 journal articles referred GenScript's services and products, making GenScript the most frequently referred biology CRO in the world. Its service portfolio includes bio-reagent services, assay development & screening, lead optimization, and antibody drug development. Their renowned one-stop bioreagent services include custom gene synthesis and molecular biology, custom protein expression and purification, custom peptide synthesis, antibody production, and custom cell line development. GenScript is headquartered in Piscataway, New Jersey, with subsidiaries in Europe, Japan, and China.


GENSCRIPT USA Inc.


860 Centennial Ave.
Piscataway, NJ 08854
USA

Press Release Source: http://PressExposure.com/PR/GENSCRIPT_USA_Inc..html

Press Release Submitted On: February 21, 2013 at 2:41 am
This article has been viewed 28283 time(s).